Kerrie E. Hargrave

Kerrie E. Hargrave

Auto-generated profile, based on publicly available information

Kerrie E. Hargrave

School of Infection and Immunity, University of Glasgow

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
Rute Maria PintoRute Maria Pinto
Rute Maria Pinto
SBSiddharth Bakshi
Siddharth Bakshi
SLSpyros Lytras
Spyros Lytras
MZMohammad Khalid Zakaria
Mohammad Khalid Zakaria
SSSimon Swingler
Simon Swingler
MPMassimo Palmarini
Massimo Palmarini
Cross-species transmission of avian influenza A viruses (IAVs) into humans could represent the first step of a future pandemic 1 . Multiple factors limiting the spillover and adaptation of avian IAVs in humans have been identified, but they are not sufficient to explain which virus lineages are more likely to cross the species barrier 1,2 . Here, we identified human BTN3A3 3 (butyrophilin subfamily 3 member A3) as a potent inhibitor of avian but not human IAVs. We determined that BTN3A3 is constitutively expressed in human airways and its antiviral activity evolved in primates. We show that BTN3A3 restriction acts at the early stages of virus replication by inhibiting avian IAV vRNA transcription. We identified residue 313 in the viral nucleoprotein (NP) as the genetic determinant of BTN3A3 sensitivity (313F, or rarely 313L in avian viruses) or evasion (313Y or 313V in human viruses). However, several serotypes of avian IAVs that spilled over into humans in recent decades evade BTN3A3 restriction. In these cases, BTN3A3 evasion is due to substitutions (N, H or Q) in NP residue 52 that is adjacent to residue 313 in the NP structure 4 . Importantly, we identified more than 150 avian IAV lineages with a BTN3A3-resistant genotype. In conclusion, sensitivity or resistance to BTN3A3 is another factor to consider in the risk assessment of the zoonotic potential of avian influenza viruses.

24 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
GFGeorge E Finney
George E Finney
KHKerrie E Hargrave
Kerrie E Hargrave
MPMarieke Pingen
Marieke Pingen
TPThomas Purnell
Thomas Purnell
DTDavid Todd
David Todd
MMMegan KL MacLeod
Megan KL MacLeod
Interferon gamma (IFN γ ) is a potent antiviral cytokine that can be produced by many innate and adaptive immune cells during infection. Currently, our understanding of which cells produce IFN γ and where they are located at different stages of an infection are limited. We have used reporter mice to investigate in vivo expression of IFN γ in the lung and secondary lymphoid organs during and following influenza A virus (IAV) infection. We observed a triphasic production of IFN γ expression. Unconventional T cells and innate lymphoid cells, particularly NK cells, were the dominant producers of early IFN γ , while CD4 and CD8 T cells were the main producers by day 10 post-infection. Following viral clearance, some memory CD4 and CD8 T cells continued to produce IFN γ in the lungs and draining lymph node. Interestingly, IFN γ production by lymph node Natural Killer (NK), NKT and innate lymphoid 1 cells also continued to be above naïve levels, suggesting memory-like phenotypes for these cells. Analysis of the localisation of IFN γ + memory CD4 and CD8 T cells demonstrated that cytokine+ T cells were located near airways and in the lung parenchyma. Following a second IAV challenge, lung IAV specific CD8 T cells rapidly increased their expression of IFN γ while CD4 T cells in the draining lymph node increased their IFN γ response. Together, these data suggest that IFN γ production fluctuates based on cellular source and location, both of which could impact subsequent immune responses.

23 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JWJulie C. Worrell
Julie C. Worrell
KHKerrie E. Hargrave
Kerrie E. Hargrave
GFGeorge E. Finney
George E. Finney
CHChris Hansell
Chris Hansell
JCJohn Cole
John Cole
MMMegan K.L MacLeod
Megan K.L MacLeod
Lung structural cells, including epithelial cells and fibroblasts, form barriers against pathogens and trigger immune responses following infections such as influenza A virus. This response leads to the recruitment of innate and adaptive immune cells required for viral clearance. Some of these recruited cells remain within the lung following infection and contribute to enhanced viral control following subsequent infections. There is growing evidence that structural cells can also display long-term changes following infection or insults. Here we investigate long-term changes to mouse lung epithelial cells, fibroblasts, and endothelial cells following influenza virus infection and find that all three cell types maintain an imprint of the infection, particularly in genes associated with communication with T cells. Lung epithelial cells from IAV-infected mice display functional changes by more rapidly controlling influenza virus than cells from naïve animals. This rapid anti-viral response and increased expression of molecules required to communicate with T cells demonstrates sustained and enhanced functions following infection. These data suggest lung structural cells could be effective targets for vaccines to boost durable protective immunity. Graphical Highlights: Lung epithelial cells, fibroblasts, and blood endothelial cells maintain an inflammatory imprint of influenza A virus (IAV) infection for at least 40 days post-infection. In vivo re-infection leads to a more spatially restricted anti-viral response compared to primary IAV-infected animals. T cells are not required for enhanced viral control early after re-infection in vivo Ex vivo lung epithelial cells from IAV-infected mice more rapidly control IAV than cells from naïve animals in the absence of immune cells.

21 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KHKerrie E Hargrave
Kerrie E Hargrave
JWJulie C Worrell
Julie C Worrell
CPChiara Pirillo
Chiara Pirillo
EBEuan Brennan
Euan Brennan
AGAndreu Masdefiol Garriga
Andreu Masdefiol Garriga
MMMegan KL MacLeod
Megan KL MacLeod
Influenza A virus (IAV) infection leads to the formation of mucosal memory CD4 T cells that can protect the host. An in-depth understanding of the signals that shape memory cell development is required for more effective vaccine design. We have examined the formation of memory CD4 T cells in the lung following IAV infection of mice, characterising changes to the lung landscape and immune cell composition. IAV-specific CD4 T cells were found throughout the lung at both primary and memory time points. These cells were found near lung airways and in close contact with a range of immune cells including macrophages, dendritic cells, and B cells. Interactions between lung IAV-specific CD4 T cells and MHCII+ cells during the primary immune response were important in shaping the subsequent memory pool. Treatment with an anti-MHCII blocking antibody increased the proportion of memory CD4 T cells found at lung airways but reduced interferon-g expression by IAV-specific immunodominant memory CD4 T cells. The immunodominant CD4 T cells expressed higher levels of PD1 than other IAV-specific CD4 T cells and PD1+ memory CD4 T cells were located further away from MHCII+ cells than their PD1-negative counterparts. This distinction in location was lost in mice treated with anti-MHCII antibody. These data suggest that sustained antigen presentation in the lung impacts on the formation of memory CD4 T cells by regulating their cytokine production and location.

15 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
LWLotus M Westerhof
Lotus M Westerhof
JNJonathan Noonan
Jonathan Noonan
KHKerrie E Hargrave
Kerrie E Hargrave
ECElizabeth T Chimbayo
Elizabeth T Chimbayo
ZCZhiling Cheng
Zhiling Cheng
MMMegan KL MacLeod
Megan KL MacLeod
Cytokine production by memory T cells is a key mechanism of T cell mediated protection. However, we have a limited understanding of the survival and secondary responses of memory T cells with cytokine producing capacities. We interrogate antigen-specific CD4 T cells using a mouse influenza A virus infection model. CD4 T cells with the capacity to produce cytokines survive better than non-cytokine+ cells, displaying a low fold contraction and expressing high levels of pro-survival molecules, CD127 and Bcl2. Transcriptomic analysis reveals a heterogenous population of memory CD4 T cells with three clusters of cytokine+ cells. These clusters match flow cytometry data revealing an enhanced survival signature in cells capable of producing multiple cytokines. These multifunctional cells are, however, less likely to proliferate during and following primary and secondary infections. Despite this, multifunctional memory T cells form a substantial fraction of the secondary memory pool, indicating that survival rather than proliferation may dictate which populations survive within the memory pool.